There appears to be no link between high blood pressure in the first two days after an acute episode of thrombotic thrombocytopenic purpura (TTP)…
News
IMMUNE THROMBOCYTOPENIA
NewsBoosting platelet counts in ITP is aim of efgartigimod study
A Phase 3 trial testing efgartigimod administered into a vein in adults with primary immune thrombocytopenia (ITP) is still enrolling participants and its top-line…
VON WILLEBRAND DISEASE
NewsDental procedures may lead to bleeding in VWD, hemophilia
People with von Willebrand disease (VWD) or hemophilia may experience bleeding complications after dental procedures, a new study highlights. Bleeding after such procedures, notably…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsHigh LDH may signal mortality risk in immune-mediated TTP
High levels of lactate dehydrogenase (LDH) in the blood — a sign that tissues and organs may have been damaged — may also signal a…
IMMUNE THROMBOCYTOPENIA
NewsDoptelet, Doptelet Sprinkle for pediatric ITP win FDA approval
Sobi’s Doptelet (avatrombopag), which is available as a tablet and an oral granule called Doptelet Sprinkle, is now approved in the U.S. for children…
VON WILLEBRAND DISEASE
NewsHormonal therapy does not seem to lighten heavy periods in VWD
Hormonal therapy may not be as effective as previously believed to control heavy menstrual bleeding in women with type 1 von Willebrand disease (VWD),…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsDiagnosing, treating TTP promptly improves pregnancy outcomes
Acquired thrombotic thrombocytopenic purpura (TTP) during pregnancy must be distinguished from other conditions, monitored carefully, and treated promptly to ensure the best possible outcomes…
IMMUNE THROMBOCYTOPENIA
NewsGut bacteria types may influence ITP progression in children: Study
Children and adolescents newly diagnosed with immune thrombocytopenia (ITP) show clear differences in gut microbiota — the community of bacteria and other microbes living…
IMMUNE THROMBOCYTOPENIA
NewsDoptelet found safe, effective in previously treated children with ITP
Doptelet (avatrombopag) was safe and effective in children with immune thrombocytopenia (ITP) who had an insufficient response to previous treatments, according to recently…
IMMUNE THROMBOCYTOPENIA
NewsHetrombopag is safe, effective for ITP in real-world settings: Study
Hetrombopag appears to be a safe and effective option in real-world settings for immune thrombocytopenia (ITP), with better outcomes linked with a higher starting…
Recent Posts
- What I wish my parents had known after my ITP diagnosis
- Treatment may lower long-term organ damage risk in congenital TTP
- Asthma medication may help reduce platelet destruction in ITP, study finds
- Growing up with ITP meant risk evaluation became a lasting trait
- Man with VWD type 1 undergoes heart procedure without major bleeding
